1-8 of 8
Pedro de Alarcon, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Platelet Counts and Outcomes in Acute General Pediatric Patients

Jonathan Bardahl, DO, Pedro De Alarcon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5861.
https://doi.org/10.1182/blood-2019-131263
Published: 2019
Journal Articles

An in Vitro Study on the Role of Angiogenesis in Iron Deficiency Induced Reactive Thrombocytosis

Pedro De Alarcon, MD, Manu Gnanamony, PhD, Jessica Garcia, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2450.
https://doi.org/10.1182/blood-2018-99-115378
Published: 2018
Journal Articles

Histological Evaluation of Megakaryocytes and Angiogenic Signaling Molecules of Bone Marrow in Experimentally Induced Iron Deficiency Anemia

Jessica Garcia, MD, Peggy Mankin, BS, MA, Pedro De Alarcon, MD
Journal: Blood
Blood (2015) 126 (23): 953.
https://doi.org/10.1182/blood.V126.23.953.953
Published: 2015
Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD
Journal: Blood
Blood (2010) 116 (21): 766.
https://doi.org/10.1182/blood.V116.21.766.766
Published: 2010
Journal Articles

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

E. Mauricio Castellanos, M.D., Monika Metzger, L. Fulgencio Baez, Yessica Gamboa, Armando Pena Hernandez, Soad Alabi, Sandra Luna-Fineman, MD, Rosa Nieves, Pedro de Alarcon, MD
Journal: Blood
Blood (2009) 114 (22): 718.
https://doi.org/10.1182/blood.V114.22.718.718
Published: 2009
Journal Articles

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

Peter D. Cole, MD, Tanya M. Trippett, MD, Richard A. Drachtman, MD, Pedro de Alarcon, MD, Lu Chen, Cindy L. Schwartz, MD
Journal: Blood
Blood (2007) 110 (11): 2318.
https://doi.org/10.1182/blood.V110.11.2318.2318
Published: 2007
Journal Articles

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Shirley Hogan, PharmD, Joy Mitchell, CRA, Vickie Massey, MD, Louis S. Constine, MD, Lu Chen, PhD, Cindy L. Schwartz, MD
Journal: Blood
Blood (2007) 110 (11): 1896.
https://doi.org/10.1182/blood.V110.11.1896.1896
Published: 2007
Journal Articles

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen Chen, MD, PhD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Robert Guillerman, MD, Shirley Hogan, PharmD, Joy Mitchell, Alan Gamis, MD, Vicki Massey, MD, Louis S. Constine, MD, Doojduen Villaluna, MS, Richard Sposto, MD, Cindy Schwartz, MD
Journal: Blood
Blood (2005) 106 (11): 2087.
https://doi.org/10.1182/blood.V106.11.2087.2087
Published: 2005